{
  "hcp_id": "12345",
  "scenario": "retention",
  "priority": "HIGH",
  "predictions": {
    "tirosint_call_success_prob": 0.78,
    "tirosint_prescription_lift": -5.2,
    "tirosint_ngd": "DECLINER",
    "flector_call_success_prob": 0.45,
    "licart_call_success_prob": 0.62
  },
  "opening": {
    "greeting": "Good {time_of_day}, Dr. {hcp_name}. Thank you for taking the time to meet with me today.",
    "purpose": "I wanted to discuss {product_focus} and understand how we can better support your practice. I noticed your {product_focus} prescriptions have declined by approximately {trx_decline_pct}% recently, and I'd like to learn more about your current treatment approach.",
    "tone": "Professional, data-driven, consultative"
  },
  "talking_points": [
    {
      "point_id": 1,
      "topic": "Acknowledge Change & Seek Understanding",
      "message": "I see that you've been prescribing {competitive_threat} more frequently. Could you share what's driving this change? Understanding your perspective helps me ensure we're addressing your patients' needs.",
      "approved_content_refs": []
    },
    {
      "point_id": 2,
      "topic": "Reinforce Value Proposition",
      "message": "Based on your specialty in {specialty}, {product_focus} may offer specific benefits for certain patient populations. [INSERT PRODUCT-SPECIFIC APPROVED MESSAGING FROM LIBRARY]",
      "approved_content_refs": [
        "TIR-MSG-001",
        "TIR-MSG-002",
        "FLE-MSG-001",
        "LIC-MSG-001"
      ]
    },
    {
      "point_id": 3,
      "topic": "Clinical Evidence",
      "message": "Recent studies have demonstrated [INSERT CLINICAL CLAIMS FROM LIBRARY]. This may be relevant for patients who are not optimally controlled on current therapy.",
      "approved_content_refs": [
        "TIR-CLI-001",
        "TIR-CLI-002",
        "FLE-CLI-001",
        "LIC-CLI-001"
      ]
    },
    {
      "point_id": 4,
      "topic": "Address Competitive Positioning",
      "message": "I understand {competitive_threat} may have certain advantages. However, {product_focus} offers [UNIQUE DIFFERENTIATORS]. For patients with [SPECIFIC NEEDS], this could make a meaningful difference.",
      "approved_content_refs": []
    }
  ],
  "objection_handlers": {
    "price_objection": {
      "objection": "Your product is more expensive than generics/competitors",
      "response": "[USE APPROVED OBJECTION HANDLER: TIR-OBJ-001 or GEN-OBJ-001]",
      "approved_content_refs": [
        "TIR-OBJ-001",
        "GEN-OBJ-001"
      ]
    },
    "efficacy_question": {
      "objection": "I'm not seeing better results with your product",
      "response": "I appreciate that feedback. Could you tell me more about the patient population you're treating? [PRODUCT] may be particularly beneficial for patients with [SPECIFIC CHARACTERISTICS]. Let's discuss whether there might be select patients where [PRODUCT] could be a good fit.",
      "approved_content_refs": [
        "TIR-CLI-001",
        "TIR-CLI-002"
      ]
    },
    "satisfied_with_current": {
      "objection": "I'm satisfied with current therapy options",
      "response": "That's great to hear your patients are doing well. I'm not suggesting changing all patients, but rather keeping [PRODUCT] as an option for those who may not be optimally controlled or have specific needs. Would you be open to considering it for select cases?",
      "approved_content_refs": []
    }
  },
  "call_to_action": "",
  "next_steps": [
    "Leave product samples and dosing information",
    "Send clinical study reprints via email",
    "Schedule follow-up call/visit in 30 days",
    "Provide direct contact for questions",
    "Monitor TRx data for changes"
  ],
  "required_disclaimers": [
    "prescribing_info",
    "individual_results",
    "adverse_events"
  ],
  "compliance_verified": false,
  "approval_sources": [
    "WEB-TIR-BOXED-2025",
    "WEB-TIR-SYMPTOMS-2025",
    "WEB-TIR-DOSING-2025",
    "WEB-TIR-USE-2025",
    "WEB-TIR-SAVINGS-2025"
  ],
  "compliance_result": {
    "is_compliant": false,
    "violations": [
      "Fair balance violation: benefits without risks"
    ],
    "severity": "LOW",
    "prohibited_terms_found": [],
    "missing_disclaimers": [],
    "off_label_detected": false,
    "fair_balance_issues": [
      "Benefits mentioned without corresponding safety information"
    ]
  },
  "template_used": "retention",
  "rag_content_used": [
    "TIR-SAF-001-WEB",
    "TIR-CLI-001-WEB",
    "TIR-CLI-002-WEB",
    "TIR-MSG-001-WEB",
    "TIR-OBJ-001-WEB"
  ],
  "gpt4_enhanced": true,
  "generation_method": "template_rag_gpt4",
  "generation_time": 10.098898,
  "estimated_cost": 0.00045195,
  "generated_at": "2025-10-27T14:55:22.080867",
  "model_versions": {
    "phase6_models": "20251027",
    "gpt4": "gpt-4o-mini"
  }
}